Gestational Diabetes: What New Research Means for You

If you’ve been diagnosed with gestational diabetes (diabetes that develops during pregnancy), you’re far from alone — and new research released in October 2026 is reshaping how we understand, screen for, and manage this condition, both during pregnancy and long after your baby arrives.

The short version

• A major international study of 1.43 million women found gestational diabetes is linked to roughly seven times the later risk of type 2 diabetes, plus higher rates of high blood pressure and heart disease.
• The World Health Organization (WHO) is reviewing its global screening and diagnosis guidelines for hyperglycaemia (high blood glucose) in pregnancy, with an expert meeting held 20–24 October 2026.
• In Australia, almost 1 in 5 women who gave birth in 2023–24 were diagnosed with gestational diabetes, according to the Australian Institute of Health and Welfare (AIHW).
• Lifestyle changes after pregnancy — not medication — currently have the strongest evidence for cutting future type 2 diabetes risk.

What’s new in gestational diabetes research

Several significant pieces of research have landed in the past month. A large international study tracking 1.43 million women found that those who had gestational diabetes faced about seven times the rate of developing type 2 diabetes later in life, plus increased risks of hypertension (high blood pressure) and cardiovascular disease.

Separately, Swedish national data covering nearly one million pregnancies showed gestational diabetes rates climbing sharply — from 1.5% of pregnancies in 2015 to 6.6% in 2023 — with the steepest rises among women born overseas and those facing socioeconomic disadvantage. This mirrors concerns raised by Diabetes Australia and the AIHW, which report that almost one in five women giving birth in Australia in 2023–24 had gestational diabetes.

Meanwhile, the WHO has been reviewing how gestational diabetes is screened and diagnosed worldwide, with a technical expert meeting running from 20–24 October 2026. This matters because testing approaches still vary between countries — and even between hospitals in Australia — which can affect how many women are diagnosed and when.

What the evidence shows about long-term health

One of the clearest messages from this round of research is that gestational diabetes isn’t just a “pregnancy problem” that disappears after birth. It’s increasingly understood as an early warning sign for future cardiometabolic risk — meaning risk to your heart, blood vessels and blood glucose regulation down the track.

A study looking at postpartum outcomes found that women who had better blood glucose control during pregnancy tended to have healthier fasting glucose, cholesterol and triglyceride levels after delivery. This reinforces why diabetes educators encourage working closely with your healthcare team during pregnancy — good management now may support better metabolic health later.

On the prevention side, an updated systematic review pooling 25 studies and over 7,000 women found that lifestyle interventions after a gestational diabetes diagnosis — such as structured support around nutrition and movement — were associated with around a 15% reduction in future type 2 diabetes risk. Evidence for preventive medications in this context remains much less certain.

Who this affects

• Women currently pregnant with gestational diabetes: New research on glucose monitoring during labour (the UK’s GILD trial) is testing whether less frequent glucose checks can safely replace hourly finger-prick testing — potentially making labour more comfortable without compromising safety. This is still being trialled and isn’t yet standard practice.
• Women with a history of gestational diabetes: The seven-fold increased type 2 diabetes risk finding is a strong reminder that postpartum follow-up matters, not just immediately after birth but for years afterward.
• Women with genetic forms of diabetes (like MODY): Research into a rare inherited form called HNF1A-MODY found that babies born to mothers with this condition were more likely to be large for gestational age than babies of affected fathers — highlighting how a mother’s blood glucose specifically shapes fetal growth.
• Prediabetes and type 2 diabetes: These findings reinforce existing calls from Diabetes Australia for early postpartum screening and ongoing risk-reduction support.

Availability and guidance in Australia

Standard practice in Australia currently follows an oral glucose tolerance test (OGTT) around 24–28 weeks of pregnancy, with earlier testing offered to women at higher risk. The Australian Diabetes Society and RANZCOG (the Royal Australasian College of Obstetricians and Gynaecologists) provide local clinical guidance, and the National Diabetes Services Scheme (NDSS) offers support for blood glucose monitoring supplies for eligible women.

It’s worth noting that any changes stemming from the WHO’s October 2026 review would take time to filter into Australian clinical guidelines, so current testing and management approaches here remain unchanged for now. Always follow the advice of your treating team rather than overseas headlines.

One trend worth flagging cautiously: reporting shows a sharp rise in GLP-1 medication prescriptions among women with a history of gestational diabetes after pregnancy. These medicines are not approved or recommended for use during pregnancy or breastfeeding, and any decisions about them should only be made with your GP or endocrinologist, considering your full health picture, future pregnancy plans, and breastfeeding status.

Limitations and what we still don’t know

Much of this research is observational, meaning it shows strong links rather than proving direct cause and effect in every case. The WHO’s guideline review is ongoing, not finalised, so specific diagnostic thresholds could still change. Trials like GILD (less frequent glucose testing in labour) are still recruiting, so their findings aren’t yet shaping standard care. And while lifestyle prevention programs show promise, more research is needed on how best to make them accessible and sustainable for women from diverse backgrounds — particularly those the Swedish study identified as facing the steepest rises in gestational diabetes rates.

What this means for you

• If you’re currently pregnant, keep attending your scheduled glucose screening and follow the monitoring plan your care team sets out — don’t adjust testing frequency based on overseas trial news.
• If you’ve had gestational diabetes before, ask your GP about postpartum OGTT testing (usually done 4–12 weeks after birth) and ongoing screening every 1–3 years, as recommended by Diabetes Australia.
• Talk to your GP, obstetrician or a credentialled diabetes educator about a realistic, supportive lifestyle plan after birth — this currently has the best evidence for reducing future type 2 diabetes risk.
• If you’re considering any medication, including GLP-1 drugs, after a gestational diabetes pregnancy, discuss timing, breastfeeding and future pregnancy plans with your doctor first.
• Mention any family history of inherited diabetes forms like MODY if your baby was notably large at birth, as this can prompt helpful genetic conversations.

Gestational diabetes can feel overwhelming, but understanding what’s happening — and what support is available — makes a real difference. For more practical guidance, explore our other guides on Diabetes Clarity, including daily meal ideas, pregnancy-friendly recipes, and tips for navigating blood glucose monitoring with confidence.